FDA Inspection 944539 — Symogen Inc.
The FDA completed an inspection of Symogen Inc. on Oct 2, 2015 in Woodbridge, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 2, 2015
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Woodbridge, NJ (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)